Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 927

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 927
---
,347 | ​ | ​ | ​ | ​    | $ |    -20,542 | ​ | ​ |
| Denominator:                                                             | ​ | ​ | ​                              | ​ |          ​ | ​ | ​ | ​ | ​    | ​ |          ​ | ​ | ​ |
| Weighted-average common shares outstanding, basic and diluted            | ​ | ​ | ​                              | ​ | 19,134,096 | ​ | ​ | ​ | ​    | ​ | 19,116,342 | ​ | ​ |
| Net loss per share attributable to common stockholders, basic anddiluted | ​ | ​ | ​                              | $ |      -0.91 | ​ | ​ | ​ | ​    | $ |      -1.07 | ​ | ​ |

The Company’s potentially dilutive securities, which include stock options to purchase common stock and Preferred Stock, have been excluded from the computation of diluted net loss per share as the effect would be anti-dilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The following potentially dilutive securities have been excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:

| ​                                              
 ​                                              | ​ 
 ​ | ​ 
 ​ | For the Year EndedDecember 31, 
 2023                           |   |            |   | ​ | ​ | 2022 |   |            |   | ​ 
 ​ |
|:-----------------------------------------------|:--|:--|:-------------------------------|:--|-----------:|:--|:--|:--|:-----|:--|-----------:|:--|:--|
| Preferred stock (as converted to common stock) | ​ | ​ | ​                              | ​ | 29,555,538 | ​ | ​ | ​ | ​    | ​ | 29,555,538 | ​ | ​ |
| Stock options to purchase common stock         | ​ | ​ | ​                              | ​ |  5,509,379 | ​ | ​ | ​ | ​    | ​ |  4,828,500 | ​ | ​ |

13. Commitments and Contingencies Legal Matters The Company is subject to contingent liabilities, such as legal proceedings and claims, that arise in the ordinary course of business activities. The Company accrues for loss contingencies when losses become probable and are reasonably estimable.